Michael Abrams - 10 Nov 2022 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Michael Abrams
Issuer symbol: ARTHQ
Transactions as of: 10 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Nov 2022, 20:49:08 UTC
Previous filing: 08 Jul 2022
Next filing: 08 Sep 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTH	Stock Option (right to buy)	Award	$0	+900,000		$0.000000	900,000	10 Nov 2022	Common Stock	900,000	$0.0401	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.

Content

The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.